MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0027877
Anzit Pharmaceuticals Private Limited
Anzit Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹1.23 Cr
▲ 59% YoY
Net profit · FY 2024
₹1.59 Lakh
Net margin 1.3%
EBITDA · FY 2024
₹3.99 Lakh
EBITDA margin 3.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Anzit Pharmaceuticals Private Limited
Data last updated:
Anzit Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33309PN2020PTC189078. Its GSTIN is 27AATCA1686J1Z2 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashutosh Amrendra Kumar and Santosh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 54 Vastuudyog Ajmera Colony. Ny Pimpri Chinchwad (M Corp.), Pune, Maharashtra, India – 411018.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.23 Cr, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹1.59 Lakh (net margin 1.3%) and EBITDA of ₹3.99 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 237% over three years.
Anzit Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0027877).
Company details
CIN U33309PN2020PTC189078
Registration Number 189078
Incorporation Date 13 January 2020
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0027877
Recognitions & Rankings of Anzit Pharmaceuticals
Contact details
Anzit Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressPlot No 54 Vastuudyog Ajmera Colony. Ny Pimpri Chinchwad (M Corp.), Pune, Maharashtra, India – 411018
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Anzit Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Anzit Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Anzit Pharmaceuticals Private Limited, buy the company report.
Financials of Anzit Pharmaceuticals Private Limited
FY 2025 filings availableAnzit Pharmaceuticals Private Limited reported revenue of ₹1.23 Cr (up 59% YoY) for FY 2024.
Revenue · FY 2024
₹1.23 Cr ▲ 59%
Net profit · FY 2024
₹1.59 Lakh margin 1.3%
EBITDA · FY 2024
₹3.99 Lakh margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 59%
3 years · compounded
▲ 237%
EBITDA CAGR growth
1 year
▲ 107%
3 years · compounded
▲ 255%
Revenue has grown at a compounded annual rate (CAGR) of 237% over three years, including 59% growth in the latest year. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anzit Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anzit Pharmaceuticals Private Limited
Anzit Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Amrendra Kumar | Director | 20 Oct 2021 | 5 Years 0 Months | Current |
| Santosh Kumar Singh | Director | 21 Feb 2025 | 1 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Anzit Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anzit Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anzit Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AATCA1686J1Z2 | Maharashtra | Active | 02 Mar 2020 |
To see the full GST registrations and return filing status of Anzit Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anzit Pharmaceuticals Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Santosh Kumar Singh ceased to be Additional Director on 29 Sep 2025.
AGM
Anzit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Santosh Kumar Singh ceased to be Additional Director.
Filing
Anzit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Vaishali Vitthal Shinde ceased to be Director.
Appointed
Santosh Kumar Singh was appointed as Director.
Ceased
Paresh Shahaji Chavan ceased to be Director.
Appointed
Ashutosh Amrendra Kumar was appointed as Director.
Incorporation
13 Jan 2020
Anzit Pharmaceuticals Private Limited was registered on 13 Jan 2020 with Roc Pune & aged 6 years 9 months as per MCA records.
Frequently asked questions
Anzit Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2020 (6+ years old) and is registered under CIN U33309PN2020PTC189078.
Anzit Pharmaceuticals has 2 current directors:
- Ashutosh Amrendra Kumar - Director
- Santosh Kumar Singh - Director
The latest financial statements of Anzit Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Anzit Pharmaceuticals is 27AATCA1686J1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Anzit Pharmaceuticals is U33309PN2020PTC189078. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anzit Pharmaceuticals was incorporated on 13 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
Santosh Kumar Singh ceased to be Additional Director on 29 Sep 2025. Vaishali Vitthal Shinde ceased to be Director on 28 Feb 2025. Santosh Kumar Singh was appointed as Director on 21 Feb 2025. Anzit Pharmaceuticals has 5 board changes on record in total.
Yes, Anzit Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0027877).
The registered office of Anzit Pharmaceuticals is at Plot No 54 Vastuudyog Ajmera Colony. Ny Pimpri Chinchwad M Corp., Pune, Maharashtra, India – 411018.
Anzit Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.